Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alcon's Summit Buy Highlights Increasing Consolidation In Ophthalmic Sector

This article was originally published in The Gray Sheet

Executive Summary

Alcon Labs' recent decision to purchase Summit Autonomous signals a wider trend of consolidation in the ophthalmic device arena, a sector often dismissed by the investment community in recent years as lacking high-growth potential.

You may also be interested in...



WaveLight PMA Submission For Allegretto LASIK Device Expected In 2001

WaveLight Laser Technologie AG is planning to file a premarket approval application for the Allegretto ophthalmic excimer laser system for laser-assisted in situ keratomileusis (LASIK) by the end of 2001, the Germany-based company says.

WaveLight PMA Submission For Allegretto LASIK Device Expected In 2001

WaveLight Laser Technologie AG is planning to file a premarket approval application for the Allegretto ophthalmic excimer laser system for laser-assisted in situ keratomileusis (LASIK) by the end of 2001, the Germany-based company says.

Ciba Vision Merger Expands Wesley Jessen Specialty Lens Reach Worldwide

Wesley Jessen will leverage Ciba Vision's international distribution infrastructure to break into a virtually undeveloped worldwide market for specialty contact lenses.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013445

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel